(0.03%) 5 470.97 points
(0.04%) 39 128 points
(0.32%) 17 774 points
(-0.25%) $80.63
(-5.04%) $2.62
(-0.90%) $2 309.80
(-0.37%) $28.76
(3.07%) $1 016.70
(0.35%) $0.936
(0.74%) $10.68
(0.52%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders...
Stats | |
---|---|
Dagens volum | 629 030 |
Gjennomsnittsvolum | 713 030 |
Markedsverdi | 3.43M |
EPS | $-1.188 ( Q2 | 2021-08-16 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-1.845 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0530 (1.54%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-09-09 | Coelho Mary Theresa | Buy | 10 310 | Stock option (right to buy) |
2021-08-11 | Coelho Mary Theresa | Buy | 0 | |
2021-07-09 | Pennington James | Buy | 100 000 | Stock option (right to buy) |
2021-06-30 | Schneiderman Daniel H | Buy | 250 000 | Stock option (right to buy) |
2021-06-30 | Schneiderman Daniel H | Buy | 35 006 | Stock option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 81 transactions |
Buy: 5 836 949 | Sell: 2 173 162 |
Volum Korrelasjon
AzurRx BioPharma Inc Korrelasjon
10 Mest negative korrelasjoner | |
---|---|
FTIV | -0.835 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
AzurRx BioPharma Inc Korrelasjon - Valuta/Råvare
AzurRx BioPharma Inc Økonomi
Annual | 2020 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-5 902 903 |
FY | 2020 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-5 902 903 |
FY | 2019 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-6.77 |
FY | 2018 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-8.77 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
AzurRx BioPharma Inc
AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. The company is headquartered in Brooklyn, New York and currently employs 12 full-time employees. The firm is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal (GI) disorders. The firm's product pipeline consists of two therapeutic proteins, such as MS1819 and AZX1101. MS1819 is an acid-resistant secreted lipase produced by Yarrowia lipolytica, known as LIP2, that the Company is developing through recombinant deoxyribonucleic acid (DNA) technology for the treatment of exocrine pancreatic insufficiency (EPI), associated with chronic pancreatitis (CP) and cystic fibrosis (CF). AZX1101 is a recombinant-lactamase combination of bacterial origin under development for the prevention of hospital-acquired infections by resistant bacterial strains induced by parenteral administration of b-lactam antibiotics (known as nosocomial infections), as well as the prevention of antibiotic-associated diarrhea (AAD).
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.